Back
Greek Organisation of Football Prognostics SA Vs. Keros Therapeutics Industry Stock Comparison
Sell
38
GOFPY
Greek Organisation of Football Prognostics SA
Last Price:
7.99
Seasonality Move:
-3.13%
Sell
27
KROS
Keros Therapeutics
Last Price:
45.71
Seasonality Move:
4.22%
Sell
38
Greek Organisation of Football Prognostics SA (GOFPY)
is a Sell
Is Greek Organisation of Football Prognostics SA a Buy, Sell or Hold?
- The current Greek Organisation of Football Prognostics SA [GOFPY] share price is $7.99. The Score for GOFPY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- GOFPY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GOFPY Stock Price Chart
What is Greek Organisation of Football Prognostics SA's stock price today?
-
The Greek Organisation of Football Prognostics SA share price today is $7.99
The current trend is relatively stagnant and GOFPY is experiencing slight buying pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $45.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
GOFPY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 49.2 | Sell |
Chaikin Money Flow: | 228 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.81 - 8.09) | Buy |
Bollinger Bands (100): | (8.11 - 9.05) | Sell |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.79 | Sell |
Relative Strength Index (14 RSI): | 38.41 | Sell |
Chaikin Money Flow: | 239305 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.72 - 49.1) | Sell |
Bollinger Bands (100): | (49.87 - 64.91) | Sell |
GOFPY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.85 | Buy |
20-day SMA: | 7.94 | Buy |
50-day SMA: | 8.21 | Sell |
200-day SMA: | 8.42 | Sell |
8-day EMA: | 7.93 | Buy |
20-day EMA: | 7.97 | Buy |
50-day EMA: | 8.17 | Sell |
200-day EMA: | 8.38 | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.61 | Buy |
20-day SMA: | 47.29 | Sell |
50-day SMA: | 51.65 | Sell |
200-day SMA: | 47.07 | Sell |
8-day EMA: | 45.93 | Sell |
20-day EMA: | 47.34 | Sell |
50-day EMA: | 50.89 | Sell |
200-day EMA: | 50 | Sell |
Greek Organisation of Football Prognostics SA Earnings Growth & GOFPY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Greek Organisation of Football Prognostics SA Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |